Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicenter, double-blind, phase 3B study to compare the safety and clinical efficacy of levofloxacin in 750mg for 2 weeks and levofloxacin 750mg for 3 weeks to that of levofloxacin 500mg for 4 weeks in the treatment of chronic prostatitis.

Next Previous
X
Search
Trial Profile

A multicenter, double-blind, phase 3B study to compare the safety and clinical efficacy of levofloxacin in 750mg for 2 weeks and levofloxacin 750mg for 3 weeks to that of levofloxacin 500mg for 4 weeks in the treatment of chronic prostatitis.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 16 Sep 2013

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Levofloxacin (Primary)
  • Indications Bacterial infections; Prostatitis
  • Focus Therapeutic Use
  • Sponsors Janssen Research & Development

    • Most Recent Events

    • 15 Apr 2010 Results published in Current Medical Research and Opinion.
    • 23 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Oct 2008 Preliminary results were published in the proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America - A Joint Meeting, 25 Oct 2008.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top